Guo, H., Ge, Y., Li, X., Yang, Y., Meng, J., Liu, J., . . . Xu, H. (2017). Targeting the CXCR4/CXCL12 axis with the peptide antagonist E5 to inhibit breast tumor progression. Signal Transduct Target Ther.
Chicago Style CitationGuo, Hua, Yangyang Ge, Xiaojin Li, Yanlian Yang, Jie Meng, Jian Liu, Chen Wang, i Haiyan Xu. "Targeting the CXCR4/CXCL12 Axis With the Peptide Antagonist E5 to Inhibit Breast Tumor Progression." Signal Transduct Target Ther 2017.
Cita MLAGuo, Hua, et al. "Targeting the CXCR4/CXCL12 Axis With the Peptide Antagonist E5 to Inhibit Breast Tumor Progression." Signal Transduct Target Ther 2017.
Atenció: Aquestes cites poden no estar 100% correctes.